For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Comments to the U.S. International Trade Commission regarding the proposed extension of the TRIPS intellectual property waiver for Covid-19 diagnostics and therapeutics.
A new working group has been tasked with redefining the Bayh-Dole Act’s march-in rights.
The Biden administration plans, without congressional approval, to change the definition of those who are considered lawfully present in the United States to include Dreamers.
Comments to the Department of Health and Human Services Regarding Medicare Drug Price Negotiation Program Guidance
Nearly 50 million Americans rely on Medicare Part D. The program must not be drastically changed until their voices have a chance to be heard.
The federal government estimates that 7.5 percent of spending on traditional Medicare in 2022 was for “improper payments,” which includes both fraud and errors in billing. For Medicaid, it was 15.6 percent.
Biden uses every new tax and regulation, regardless of how small, as a stepping stone to soon demand even more.
Don't listen to Bernie Sanders's praise of government-run health care systems; listen to the people who work in it.
Mark Cuban is bringing his disruptive skills to the pharmaceutical market, helping patients become value-conscious shoppers for health care.
Recent research has determined the mRNA vaccines lead to a slight increase in myocarditis cased. But the vaccines' benefits still outweigh the risks for the vast majority of people.